Image: Ppat.1008735.g002
Description: Overview of the use and applications of Convalescent plasma (CP) therapy. Virus-neutralizing antibodies in the plasma of a patient who recovered from COVID-19 can be administered prophylactically to prevent infection in vulnerable individuals and those with known exposure to the virus (Prophylaxis). Convalescent plasma can also be administered to infected individuals to improve the clinical outcome (Treatment). CP, convalescent plasma; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Title: Ppat.1008735.g002
Credit: Montelongo-Jauregui D, Vila T, Sultan AS, Jabra-Rizk MA (2020) Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease. PLoS Pathog 16(8): e1008735. https://doi.org/10.1371/journal.ppat.1008735
Author: Daniel Montelongo-Jauregui, Taissa Vila, Ahmed S. Sultan, and Mary Ann Jabra-Rizk
Usage Terms: Creative Commons Attribution 4.0
License: CC BY 4.0
License Link: https://creativecommons.org/licenses/by/4.0
Attribution Required?: Yes
Image usage
There are no pages that link to this image.